Innovation1 Biotech Inc (MYYZ) Annual Balance Sheets

Annual · GAAP · USD millions
Access MYYZ quarterly Balance Sheets →
This page allows investors to track Innovation1 Biotech Inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Aug 31 2023)
(Aug 31 2022) (Aug 31 2021) (Aug 31 2020) (Aug 31 2019)
Assets
Cash & cash equivalent0.00
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments0.00
Accounts receivable0.01
Other Receivables0.00
Inventories0.00
Other Current Assets0.05
Total loans net0.02
Total Current Assets0.07
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Long-term investments0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.05
Operating Lease Right Of Use Asset0.00
Operating Lease Right Of Use Asset0.00
Total Assets0.08
Liabilities
Accounts Payable0.35
Accrued Liabilities, Current1.07
Financial Instruments0.00
Short-term Debt0.01
Other Liabilities, Current1.86
Total Current Liabilities3.29
Long-term Debt Convertible0.22
Total Long-term Debt0.22
Other liabilities, Noncurrent0.00
Accrued Expenses Related Parties0.00
Mioxal Liability Current Portion0.00
Mioxal Liability-
Total Liabilities3.51
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock55.17
Retained Earnings / Accumulated Deficit-58.63
Other Equity0.01
Common Stockholder's Equity-3.43
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-3.43
Liabilities & Stockholder's Equity0.08
4 historic quarters locked

Sign in to unlock the full Innovation1 Biotech Inc balance sheet history.

About Innovation1 Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240229)
  • Filed with the SEC: May 6, 2025
  • Source: g084799_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001753926-25-000753

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License